Study of C1QTNF4: Potential Drug Target Or Biomarker (G114900)

Target Name: C1QTNF4

NCBI ID: G114900

C1QTNF4

Study of C1QTNF4: Potential Drug Target Or Biomarker

C1QTNF4 (C1QT4_HUMAN), a gene that encodes a protein known as C1QTNF4, has been identified as a potential drug target or biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its unique structure and function have made it an attractive target for researchers to study, and its potential as a drug or biomarker has generated a great deal of interest in the scientific community.

The C1QTNF4 protein is a member of the Interleukin-6 (IL-6) signaling pathway, a network of proteins that play a crucial role in regulating immune and inflammatory responses. IL-6 is a cytokine that is involved in the regulation of immune cell function, and has been implicated in the development and progression of many diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

The C1QTNF4 protein is expressed in a wide range of tissues and cells, including immune cells, tissues, and organs. It is involved in the regulation of immune cell function and has been shown to play a role in the development and progression of cancer. For example, studies have shown that high levels of C1QTNF4 are associated with poor prognosis in patients with pancreatic cancer, a highly aggressive form of cancer that is characterized by the formation of tumors that infiltrate the surrounding tissue and have a high ability to invade and metastasize.

In addition to its potential role in cancer, C1QTNF4 has also been shown to be involved in the development and progression of neurodegenerative diseases. For example, studies have shown that C1QTNF4 is involved in the regulation of neuroprotective enzymes, which are enzymes that help to maintain the health and function of nerve cells. The loss of these enzymes has been implicated in the development of neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease.

C1QTNF4 has also been shown to be involved in the regulation of autoimmune disorders, which are conditions in which the immune system attacks the body's own tissues or organs. For example, studies have shown that C1QTNF4 is involved in the regulation of the immune response and has been implicated in the development and progression of autoimmune disorders such as rheumatoid arthritis and multiple sclerosis.

Despite its potential as a drug target or biomarker, the study of C1QTNF4 has been relatively limited. Research into its function and regulation has been primarily focused on its involvement in cancer, neurodegenerative diseases, and autoimmune disorders. There is currently a need for further research to fully understand the role of C1QTNF4 in these diseases and to develop new treatments based on its unique properties.

In conclusion, C1QTNF4 is a gene that has the potential to be a drug target or biomarker for a wide range of diseases. Its unique structure and function as a member of the IL-6 signaling pathway make it an attractive target for researchers to study. Further research is needed to fully understand its role in cancer, neurodegenerative diseases, and autoimmune disorders, and to develop new treatments based on its unique properties.

Protein Name: C1q And TNF Related 4

Functions: May be involved in the regulation of the inflammatory network. Its role as pro- or anti-inflammatory seems to be context dependent (PubMed:21658842, PubMed:27086950). Seems to have some role in regulating food intake and energy balance when administered in the brain. This effect is sustained over a two-day period, and it is accompanied by decreased expression of orexigenic neuropeptides in the hypothalamus 3 hours post-injection (By similarity)

The "C1QTNF4 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about C1QTNF4 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets